Cooperative lipolytic control of neuronal triacylglycerol by spastic paraplegia-associated enzyme DDHD2 and ATGL.

Lipolysis and fatty acid metabolism brain lipids enzymology lipase lipid droplets neurons spastic paraplegia triacylglycerol

Journal

Journal of lipid research
ISSN: 1539-7262
Titre abrégé: J Lipid Res
Pays: United States
ID NLM: 0376606

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 13 07 2023
revised: 01 10 2023
accepted: 04 10 2023
medline: 27 11 2023
pubmed: 14 10 2023
entrez: 13 10 2023
Statut: ppublish

Résumé

Intracellular lipolysis-the enzymatic breakdown of lipid droplet-associated triacylglycerol (TAG)-depends on the cooperative action of several hydrolytic enzymes and regulatory proteins, together designated as lipolysome. Adipose triglyceride lipase (ATGL) acts as a major cellular TAG hydrolase and core effector of the lipolysome in many peripheral tissues. Neurons initiate lipolysis independently of ATGL via DDHD domain-containing 2 (DDHD2), a multifunctional lipid hydrolase whose dysfunction causes neuronal TAG deposition and hereditary spastic paraplegia. Whether and how DDHD2 cooperates with other lipolytic enzymes is currently unknown. In this study, we further investigated the enzymatic properties and functions of DDHD2 in neuroblastoma cells and primary neurons. We found that DDHD2 hydrolyzes multiple acylglycerols in vitro and substantially contributes to neutral lipid hydrolase activities of neuroblastoma cells and brain tissue. Substrate promiscuity of DDHD2 allowed its engagement at different steps of the lipolytic cascade: In neuroblastoma cells, DDHD2 functioned exclusively downstream of ATGL in the hydrolysis of sn-1,3-diacylglycerol (DAG) isomers but was dispensable for TAG hydrolysis and lipid droplet homeostasis. In primary cortical neurons, DDHD2 exhibited lipolytic control over both, DAG and TAG, and complemented ATGL-dependent TAG hydrolysis. We conclude that neuronal cells use noncanonical configurations of the lipolysome and engage DDHD2 as dual TAG/DAG hydrolase in cooperation with ATGL.

Identifiants

pubmed: 37832604
pii: S0022-2275(23)00130-X
doi: 10.1016/j.jlr.2023.100457
pmc: PMC10665947
pii:
doi:

Substances chimiques

Triglycerides 0
Lipase EC 3.1.1.3
DDHD2 protein, human EC 3.1.1.-
Phospholipases EC 3.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100457

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nat Chem Biol. 2013 Dec;9(12):785-7
pubmed: 24096302
J Biol Chem. 2012 Nov 30;287(49):41446-57
pubmed: 23066022
Am J Hum Genet. 2012 Dec 7;91(6):1073-81
pubmed: 23176823
Cell Mol Life Sci. 2015 Oct;72(20):3931-52
pubmed: 26153463
Protein Cell. 2018 Feb;9(2):178-195
pubmed: 28677105
J Biol Chem. 2016 Aug 26;291(35):18562-81
pubmed: 27402848
Front Cell Dev Biol. 2022 Apr 14;10:863907
pubmed: 35493070
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14924-9
pubmed: 25267624
J Lipid Res. 2014 Dec;55(12):2471-8
pubmed: 25114172
Anal Chem. 2022 Apr 5;94(13):5325-5334
pubmed: 35315655
Genes Dev. 2013 Mar 1;27(5):459-84
pubmed: 23475957
Biochemistry. 2018 Feb 06;57(5):827-838
pubmed: 29278326
J Biol Chem. 2010 Jun 25;285(26):20192-201
pubmed: 20424161
J Lipid Res. 2008 May;49(5):1137-46
pubmed: 18281723
Biochim Biophys Acta. 2014 Apr 4;1841(4):574-80
pubmed: 24369119
FEBS Lett. 2010 Nov 5;584(21):4389-95
pubmed: 20932832
Biochem Biophys Res Commun. 1987 Oct 14;148(1):99-105
pubmed: 3675597
EBioMedicine. 2020 Mar;53:102696
pubmed: 32143183
PLoS One. 2018 Nov 7;13(11):e0206123
pubmed: 30403723
J Cell Biol. 2021 Jul 5;220(7):
pubmed: 34152362
Methods Enzymol. 2014;538:171-93
pubmed: 24529439
PLoS Biol. 2020 Jan 21;18(1):e3000595
pubmed: 31961851
J Biol Chem. 2011 May 20;286(20):17467-77
pubmed: 21454566
Science. 2006 May 5;312(5774):734-7
pubmed: 16675698
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Biol Chem. 2016 Jan 8;291(2):913-23
pubmed: 26565024
J Lipid Res. 2013 Feb;54(2):425-35
pubmed: 23220585
J Lipid Res. 2014 Apr;55(4):739-46
pubmed: 24511104
Sci Rep. 2014 Nov 24;4:7132
pubmed: 25417924
J Neurochem. 2011 Dec;119(5):1016-28
pubmed: 21951135
Elife. 2021 Feb 04;10:
pubmed: 33538247
Neuron. 2020 Jan 22;105(2):276-292.e5
pubmed: 31786011
J Biol Chem. 2006 Dec 29;281(52):40236-41
pubmed: 17074755
Prog Lipid Res. 2021 Apr;82:101084
pubmed: 33387571
Am J Physiol Endocrinol Metab. 2015 May 15;308(10):E879-90
pubmed: 25783895
EMBO Rep. 2020 Nov 5;21(11):e50214
pubmed: 33034119
PLoS Genet. 2017 May 1;13(5):e1006716
pubmed: 28459858
J Neurol. 2019 Nov;266(11):2657-2664
pubmed: 31302745
J Lipid Res. 2013 Aug;54(8):2185-2194
pubmed: 23740967
Biochim Biophys Acta. 2012 Apr;1823(4):930-9
pubmed: 22922100
J Biol Chem. 2009 Sep 25;284(39):26620-30
pubmed: 19632984
Nat Genet. 2008 Dec;40(12):1461-5
pubmed: 18820647
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun;1864(6):880-899
pubmed: 30367950
J Biol Chem. 2002 Feb 15;277(7):4806-15
pubmed: 11717312
Cell Metab. 2006 May;3(5):309-19
pubmed: 16679289
Hepatology. 2012 Jul;56(1):270-80
pubmed: 22271167
Cell Rep. 2013 Oct 31;5(2):508-20
pubmed: 24095738
Mol Metab. 2021 May;47:101174
pubmed: 33549847
Acta Neuropathol. 2013 Sep;126(3):307-28
pubmed: 23897027
Nat Commun. 2021 Dec 21;12(1):7362
pubmed: 34934077
Nat Metab. 2021 Nov;3(11):1445-1465
pubmed: 34799702
Cell Death Dis. 2018 Jul 23;9(8):797
pubmed: 30038238
J Biol Chem. 2002 Mar 29;277(13):11329-35
pubmed: 11788596
Eur J Hum Genet. 2013 Nov;21(11):1214-8
pubmed: 23486545
Science. 2005 Feb 18;307(5712):1098-101
pubmed: 15718470
J Lipid Res. 2010 Mar;51(3):490-9
pubmed: 19965578
Science. 2004 Nov 19;306(5700):1383-6
pubmed: 15550674
Biomol Concepts. 2012 Oct;3(5):471-8
pubmed: 25436551
Metabolites. 2020 Apr 10;10(4):
pubmed: 32290093

Auteurs

Peter Hofer (P)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Gernot F Grabner (GF)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Mario König (M)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Hao Xie (H)

Institute of Molecular Biosciences, University of Graz, Graz, Austria; State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, China.

Dominik Bulfon (D)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Anton E Ludwig (AE)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Heimo Wolinski (H)

Institute of Molecular Biosciences, University of Graz, Graz, Austria; BioHealth Field of Excellence, University of Graz, Graz, Austria.

Robert Zimmermann (R)

Institute of Molecular Biosciences, University of Graz, Graz, Austria; BioHealth Field of Excellence, University of Graz, Graz, Austria; BioTechMed-Graz, Graz, Austria.

Rudolf Zechner (R)

Institute of Molecular Biosciences, University of Graz, Graz, Austria; BioHealth Field of Excellence, University of Graz, Graz, Austria; BioTechMed-Graz, Graz, Austria.

Christoph Heier (C)

Institute of Molecular Biosciences, University of Graz, Graz, Austria; BioHealth Field of Excellence, University of Graz, Graz, Austria; BioTechMed-Graz, Graz, Austria. Electronic address: christoph.heier@uni-graz.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH